July 10, 2018 : DCMS #405

DISASTERS AVERTED — Near Miss Case Studies

The Real Story Continues

EXCLUSIVE INTERVIEW — Candid Video Interviews with Top Practitioners

Laura Shane-McWhorter on Nutritional Supplements, CVD and Diabetes

HOMERUN SLIDES — Great Clinical Presentation Highlights

Future Use of Technology in Outpatient Care Part 6

CLINICAL GEMS — The Best from Diabetes Texts

International Textbook of Diabetes Mellitus, 4th Ed., Excerpt #133: Pathogenesis of Type 2 Diabetes Mellitus Part 4

MOST POPULAR ARTICLES OF THE MONTH

#1 Relationship Between HbA1c and Stroke Risk
#2 Prevent Diabetes With Intermittent Fasting?
#3 Beware: White Coat Hypertension Can Increase Risk of Death by 80%

We have been working with Laura Shane-McWhorter, PharmD, BCPS, FASCP, CDE, BC-ADM, from the University of Utah for quite a few years. Seven years ago, she sat down with Steve and discussed diabetes topics. Not only is she an expert in pharmacy care, but she is very knowledgeable in nutritional support for disease states that affect our patients.

This is a good thing because if you think there is a lot of false news in politics, the false news and health claims for nutritional products that “cure” every known disease is at least 100-fold.

Professor Shane-McWhorter was recently at the AACE meeting in Boston, and Steve had a great chat with her on what really works nutritionally for patients with cardiovascular disease and diabetes.

Editor-in-chief

When we first met this patient, he did not think he was getting the right treatment. When he visited one week later…

When I asked him, and told him I would not judge him, he admitted to drinking a tea his mother recommended to bring down his glucose. He then mentioned several other supplements. His glucose was not lower, but higher.

Laura Shane-McWhorter, PharmD, BCPS, BC-ADM, CDE, FASCP, FAADE is a Professor (Clinical) Emeritus in the Department of Pharmacotherapy at the University of Utah College of Pharmacy.  She obtained her Bachelor of Arts Degree in Psychology and Chemistry at the University of Texas at Austin. She obtained a Master of Science at East Texas State University (now Texas A&M Commerce) in Biology and Chemistry.  After completing both her Bachelor of Science and Doctor of Pharmacy at the University of Utah, she did an ASHP Residency in Geriatrics. She is a Board-Certified Pharmacotherapy Specialist, is Board Certified in Advanced Diabetes Management and is a Certified Diabetes Educator.  She is a Fellow of the American Society of Consultant Pharmacists and a Fellow of the American Association of Diabetes Educators (AADE). She is a member of the Board of Directors of the American Association of Diabetes Educators.

In this week’s Homerun Slides, finding the solution to ineffective disease management.

Type 2 diabetes with hypoinsulinemia: A large body of clinical and experimental evidence documents that hyperinsulinemia and insulin resistance precede the onset of T2DM. Nonetheless, a number of studies have shown that absolute insulin deficiency, with or without impaired tissue insulin sensitivity, can lead to the development of T2DM. This scenario is best exemplified by patients with maturity onset diabetes of youth (MODY) [69–71]. This familial subtype of T2DM is characterized by early age of onset, autosomal dominant inheritance with high penetrance, mild-to-moderate fasting hyperglycemia, and impaired insulin secretion.

New meta-analysis striving to expand on the notion that glycemic control and stroke risk are closely associated.

It can improve insulin sensitivity, pancreatic response to blood sugars, and even prevent prediabetes from turning into diabetes.

Elevated BP readings at the doctor’s office linked to higher mortality than for those with consistently normal blood pressure.